This newslink doesn't exist or it was removed.
Go to Homempage.
Forbes USA Tech January 19, 2023
A gymnast grabs two rings - one in each hand.univsport.com The current generation of monoclonal antibodies is ineffective against the predominant variants of SARS-CoV-2 in circulation. Recent studies by Callaway et al. open the possibility that a new type of monoclonal antibody... + más
The Bivalent Booster Protects Against New COVID-19 Variants, New Data Show | Time
FDA Experts Vote to Make All COVID-19 Vaccines and Boosters Bivalent | Time
Time USA Health January 27, 2023
AstraZeneca Plc’s COVID antibody drug is no longer authorized for use in the U.S., regulators said Thursday, as it’s unlikely to work against strains of the virus that are now dominant across the country. Astra’s drug, called Evusheld, was authorized in December 2021 to... + más
FDA withdraws emergency use authorization of COVID drug because it is unlikely to be effective against new variants | ABC News
FDA halts authorization of Evusheld, citing medication insufficient against viral COVID-19 variants | ABC7
Orlando Sentinel USA Opinion April 13, 2023
Universal health care is one of the issues that won’t go away in America, and President Donald Trump’s recent positive COVID-19 diagnosis could have shifted the dial on it. As a Brit, I grew up with the ultimate in universal health care — the United Kingdom’s National... + más
See Inside the Soon-to-Open Super Nintendo World at Universal Studios Hollywood | NBC 6 South Florida
Universal announces new Texas theme park, horror-themed Las Vegas experience | Orlando Sentinel
The Hill USA Health December 02, 2022
RIP , the singer-songwriter responsible for some of Fleetwood Mac’s biggest hits. Today in health, the rise of new COVID-19 omicron subvariants BQ.1 and BQ.1.1 has led to the one remaining monoclonal antibody treatment no longer being authorized by the FDA. and .... + más
ALS drug wins FDA approval despite questionable data | ABC News
FDA pauses authorization for last remaining COVID-19 monoclonal antibody treatment | The Hill
The Boston Globe USA Business April 26, 2023
Cambridge scientists are deploying a novel gene-silencing technology used against ultra-rare diseases in a new effort to subdue Alzheimer’s, the memory-raving disorder that afflicts tens of millions of people worldwide.In findings reported Wednesday afternoon, Alnylam... + más
Alnylam halts work on eye drug, citing new US law over pricing | The Boston Globe
Reimagining Alzheimer’s (Part 8): APOE4 Removal Reduces Symptoms Of Alzheimer’s Disease | Forbes
About iurex | Privacy Policy | Disclaimer |